Placement Pending

Remix Therapeutics placement

US$100m raised

Announced 24 Jun 2026

Advisers

Remix Therapeutics

Issuer

Not disclosed

Lead managers

Legal adviser
Issuer
Remix Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.